相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Situ Polymerized Hollow Mesoporous Organosilica Biocatalysis Nanoreactor for Enhancing ROS-Mediated Anticancer Therapy
Ling Li et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy
Anne McMahon et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification
Wencheng Wu et al.
ADVANCED MATERIALS (2020)
A Multistage Cooperative Nanoplatform Enables Intracellular Co-Delivery of Proteins and Chemotherapeutics for Cancer Therapy
Peng Zhang et al.
ADVANCED MATERIALS (2020)
Programmable co-assembly of various drugs with temperature sensitive nanogels for optimizing combination chemotherapy
Hao Zhao et al.
CHEMICAL ENGINEERING JOURNAL (2020)
A metal-phenolic network-based multifunctional nanocomposite with pH-responsive ROS generation and drug release for synergistic chemodynamic/photothermal/chemo-therapy
Xiangyu Meng et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Strategies to improve tumor penetration of nanomedicines through nanoparticle design
Ya-Ru Zhang et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2019)
Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition
Wencheng Wu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
O2-Cu/ZIF-8@Ce6/ZIF-8@F127 Composite as a Tumor Microenvironment-Responsive Nanoplatform with Enhanced Photo-/Chemodynamic Antitumor Efficacy
Zhongxi Xie et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Transcytosis of Nanomedicine for Tumor Penetration
Yan Liu et al.
NANO LETTERS (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment
Mohammad Najlah et al.
PHARMACEUTICS (2019)
Metal Ion/Tannic Acid Assembly as a Versatile Photothermal Platform in Engineering Multimodal Nanotheranostics for Advanced Applications
Tao Liu et al.
ACS NANO (2018)
Nanoscale Metal-Organic Frameworks for Therapeutic, Imaging, and Sensing Applications
Kuangda Lu et al.
ADVANCED MATERIALS (2018)
Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy
Qiong Wu et al.
BIOMATERIALS (2018)
Optimization of combination chemotherapy with dose adjustment using a memetic algorithm
Peilian Wang et al.
INFORMATION SCIENCES (2018)
An all-in-one antitumor and anti-recurrence/metastasis nanomedicine with multi-drug co-loading and burst drug release for multi-modality therapy
Ji-Chun Yang et al.
CHEMICAL SCIENCE (2018)
Recent advances of cocktail chemotherapy by combination drug delivery systems
Quanyin Hu et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations
Hamidreza Fasehee et al.
JOURNAL OF NANOBIOTECHNOLOGY (2016)
The cytotoxic mechanisms of disulfiram and copper(II) in cancer cells
Patricia Erebi Tawari et al.
TOXICOLOGY RESEARCH (2015)
Optimized Metal-Organic-Framework Nanospheres for Drug Delivery: Evaluation of Small-Molecule Encapsulation
Jia Zhuang et al.
ACS NANO (2014)
Inhibitory effect of Disulfiram/copper complex on non-small cell lung cancer cells
Lincan Duan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
On the interaction of copper(II) with disulfiram
David J. Lewis et al.
CHEMICAL COMMUNICATIONS (2014)
Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo
Peng Liu et al.
ONCOTARGET (2014)
Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies
Concetta Conticello et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells
Zdenek Skrott et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
N. C. Yip et al.
BRITISH JOURNAL OF CANCER (2011)
Disulfiram Is a DNA Demethylating Agent and Inhibits Prostate Cancer Cell Growth
Jianqing Lin et al.
PROSTATE (2011)
Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
Xiaoxia Guo et al.
CANCER LETTERS (2010)
Nanoparticle-assisted combination therapies for effective cancer treatment
Che-Ming Jack Hu et al.
THERAPEUTIC DELIVERY (2010)
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Anshul Gupte et al.
CANCER TREATMENT REVIEWS (2009)
High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
Kristiina Iljin et al.
CLINICAL CANCER RESEARCH (2009)
Targeting of nuclear Factor-kappa B and proteasome by dithiocarbamate complexes with metals
B. Cvek et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
Di Chen et al.
CANCER RESEARCH (2006)
分享论文
